MUTANTE INTERLEUKIN-2-POLYPEPTIDE

European patent · EP3075745 · Deleted

Register entry

Publication number
EP3075745
Application number
EP16164244
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 7, 2012
Published
Oct 5, 2016
Granted
Sep 5, 2018
Deleted
Sep 24, 2024
Reason
Annual fee unpaid
IPC classes
C07K 14/55 (2006.01)
C12N 15/26 (2006.01)
A61K 39/395 (2006.01)
C07K 16/46 (2006.01)
C07K 19/00 (2006.01)
C07K 14/54 (2006.01)
A61K 38/20 (2006.01)
C07K 16/30 (2006.01)
C07K 16/40 (2006.01)
A61K 39/00 (2006.01)
A61K 47/68 (2017.01)
Priority
EP 11153964 10.02.2011
EP 11164237 29.04.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 24, 2024

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.09.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.09.2024

  2. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  3. Oct 19, 2021

    Address changed

    Owner
    Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren

    Published in Swissreg on 19.10.2021

  4. Sep 5, 2018

    Granted

    Published in Swissreg on 05.09.2018

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.